Prelude Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19M | Sell |
50,823
-18
| -0% | -$777 | 0.21% | 122 |
|
|
2025
Q1 | $1.76M | Sell |
50,841
-17,859
| -26% | -$617K | 0.13% | 145 |
|
|
2024
Q4 | $1.89M | Buy |
68,700
+7,550
| +12% | +$207K | 0.12% | 170 |
|
|
2024
Q3 | $1.56M | Buy |
61,150
+37,839
| +162% | +$963K | 0.09% | 238 |
|
|
2024
Q2 | $590K | Buy |
23,311
+11,797
| +102% | +$299K | 0.04% | 412 |
|
|
2024
Q1 | $356K | Sell |
11,514
-3,740
| -25% | -$116K | 0.02% | 723 |
|
|
2023
Q4 | $616K | Buy |
15,254
+40
| +0.3% | +$1.62K | 0.04% | 364 |
|
|
2023
Q3 | $401K | Sell |
15,214
-3,827
| -20% | -$101K | 0.03% | 449 |
|
|
2023
Q2 | $328K | Buy |
19,041
+3,764
| +25% | +$64.7K | 0.02% | 515 |
|
|
2023
Q1 | $253K | Sell |
15,277
-8,124
| -35% | -$135K | 0.02% | 652 |
|
|
2022
Q4 | $178K | Buy |
+23,401
| New | +$178K | 0.01% | 862 |
|